0000000001307492

AUTHOR

Tanmoy Sadhukha

showing 5 related works from this author

Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo

2015

Following recent work on heterometallic titanocene-gold complexes as potential chemotherapeutics for renal cancer, we report here on the synthesis, characterization and stability studies of new titanocene complexes containing a methyl group and a carboxylate ligand (mba = S-C6H4-COO-) bound to gold(I)-phosphane fragments through a thiolate group ([(η-C5H5)2TiMe(μ-mba)Au(PR3)]. The compounds are more stable in physiological media than those previously reported and are highly cytotoxic against human cancer renal cell lines. We describe here preliminary mechanistic data involving studies on the interaction of selected compounds with plasmid (pBR322) DNA used as a model nucleic acid, and with s…

BiochemistryChemistryKinaseCell cultureIn vivoCancer cellCytotoxic T cellGeneral ChemistryLigand (biochemistry)Protein kinase BIn vitro3. Good healthChemical Science
researchProduct

In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Bre…

2014

A series of organometallic ruthenium(II) complexes containing iminophosphorane ligands have been synthesized and characterized. Cationic compounds with chloride as counterion are soluble in water (70–100 mg/mL). Most compounds (especially highly water-soluble 2) are more cytotoxic to a number of human cancer cell lines than cisplatin. Initial mechanistic studies indicate that the cell death type for these compounds is mainly through canonical or caspase-dependent apoptosis, nondependent on p53, and that the compounds do not interact with DNA or inhibit protease cathepsin B. In vivo experiments of 2 on MDA-MB-231 xenografts in NOD.CB17-Prkdc SCID/J mice showed an impressive tumor reduction (…

Programmed cell deathStereochemistryPhosphoranesAntineoplastic AgentsTriple Negative Breast NeoplasmsMice SCIDPharmacologyIn Vitro TechniquesArticleRutheniumIn vivoCoordination ComplexesMice Inbred NODDrug DiscoverymedicineOrganometallic CompoundsCytotoxic T cellAnimalsHumansCathepsinCisplatinChemistryWaterIn vitro3. Good healthHEK293 CellsSolubilityCell cultureApoptosisMolecular MedicineFemalemedicine.drugJournal of Medicinal Chemistry
researchProduct

Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo † †This paper is dedicated to Prof. Roberto Sánchez-Delgado, g…

2015

Heterometallic compounds as anticancer agents demonstrating in vivo potential for the first time. Titanocene–gold derivatives: promising candidates for renal cancer.

ChemistryChemical Science
researchProduct

CCDC 1008354: Experimental Crystal Structure Determination

2015

Related Article: Malgorzata Frik, Alberto Martínez, Benelita T. Elie, Oscar Gonzalo, Daniel Ramírez de Mingo, Mercedes Sanaú, Roberto Sánchez-Delgado, Tanmoy Sadhukha, Swayam Prabha, Joe W. Ramos, Isabel Marzo, and María Contel|2014|J.Med.Chem.|57|9995|doi:10.1021/jm5012337

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(eta6-p-Cymene)-chloro-(N-(triphenylphosphoranylidene)pyridine-2-carboxamide)-ruthenium(ii) hexafluorophosphateExperimental 3D Coordinates
researchProduct

CCDC 1400886: Experimental Crystal Structure Determination

2015

Related Article: Jacob Fernández-Gallardo, Benelita T. Elie, Tanmoy Sadhukha, Swayam Prabha, Mercedes Sanaú, Susan A. Rotenberg, Joe W. Ramos, María Contel|2015|Chemical Science|6|5269|doi:10.1039/C5SC01753J

Space GroupCrystallographyCrystal System(4-carboxybenzene-1-thiolato)-((ferrocen-1-yl)(diphenyl)phosphine)-gold(i)Crystal StructureCell ParametersExperimental 3D Coordinates
researchProduct